NCT06317792

Brief Summary

To validate the efficiency of online exergaming-based physiotherapy. We will enroll patients with Parkinson's disease in postural instability and gait disturbance motor phenotype in the study and divide them into two groups in a randomized controlled study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 19, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Completed
Last Updated

March 19, 2024

Status Verified

March 1, 2024

Enrollment Period

2 years

First QC Date

February 21, 2024

Last Update Submit

March 12, 2024

Conditions

Keywords

online exergaming-based physiotherapyParkinson's disease

Outcome Measures

Primary Outcomes (2)

  • Unified Parkinson's Disease Rating Scale score assessment

    The outcome measure is the Unified Parkinson's Disease Rating Scale score. The UPDRS scale consists of the following six segments: 1) Mentation, Behavior, and Mood, 2) ADL, 3) Motor sections, and 4) Complications of Therapy (in the past week) The four segments are made up of 42 items grouped into four subscales. Each item has 0-4 ratings: 0 (normal), 1 (slight), 2 (mild), 3 (moderate), and 4 (severe)

    Intervention and follow-up period through study completion, an average of 3 years

  • Tinetti balance and gait score assessment

    The score consists of two parts, including the balance score (score=0-16) and gait score (score=0-12), and ranged from 0 to 28 points by summing the points obtained for each of the two tests.

    Intervention and follow-up period through study completion, an average of 3 years

Secondary Outcomes (2)

  • Fall Risk assessment using Berg Balance Scale

    intervention and follow-up period through study completion, an average of 3 years

  • Depression severity assessment

    intervention and follow-up period through study completion, an average of 3 years

Study Arms (2)

Online exergaming-based physiotherapy intervention group

EXPERIMENTAL

The training tasks consist of a set of 10 pieces of training (20 min per session, five sessions every week, for 8 weeks)

Other: online exergaming-based physiotherapy programs

Online exergaming-based physiotherapy observation group

NO INTERVENTION

Observation only

Interventions

The online exergaming-based physiotherapy programs focus on training in shoulder, hip, and knee ROM balance, weight-bearing, strength, weight shifting, and walking based on RF in machine learning to the features selection in patients with PIGD. The training tasks consist of a set of 10 pieces of training (20 min per session, five sessions every week, for 8 weeks). Five exergaming programs were used for training, designed to incorporate an appropriate level of challenge to match the ability and fitness of patients with PD.

Online exergaming-based physiotherapy intervention group

Eligibility Criteria

Age20 Years - 90 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • . Clinical diagnosis of Parkinson's disease

You may not qualify if:

  • Moderate and severe dementia (Clinical Dementia Rating more than or equal to 2)
  • Advanced PD stage (Hoehn and Yahr staging equal or more than four)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine

Kaohsiung City, 83304, Taiwan

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Central Study Contacts

Cheng-Hsien Lu, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be divided into two groups in a randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of neurology

Study Record Dates

First Submitted

February 21, 2024

First Posted

March 19, 2024

Study Start

April 1, 2024

Primary Completion

March 31, 2026

Study Completion

June 30, 2026

Last Updated

March 19, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations